Loading clinical trials...
Loading clinical trials...
Phase II, Randomized, Placebo-controlled, Double-blind, Safety and Immunogenicity Trial of Intramuscular Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in Healthy Adults
Conditions
Interventions
Norovirus Bivalent VLP Vaccine
Placebo (Saline)
Locations
10
United States
California Research Foundation
San Diego, California, United States
Benchmark Research San Francisco
San Francisco, California, United States
Clin Research of South Florida
Coral Gables, Florida, United States
SNBL
Baltimore, Maryland, United States
St. Louis University, School of Medicine
St Louis, Missouri, United States
Rochester Clinical Research
Rochester, New York, United States
Start Date
May 15, 2014
Primary Completion Date
January 6, 2016
Completion Date
January 6, 2016
Last Updated
August 21, 2017
Lead Sponsor
Takeda
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions